MedTrace Logo

Different Acupoints Compatibility Difference of the Effect of Treatment of the Diabetic Gastroparesis

NCT02452489 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2015-05-22

No results posted yet for this study

Summary

With Diabetic gastroparesis as the research object, by the method of multi-center RCT and single cavity and different acupuncture acupoints compatibility treatment of diabetic gastroparesis, the inspection of gastric emptying, gastric dynamic inspection, such as validity checking means, for single cavity with different acupoints compatibility evaluate clinical efficacy of treatment of diabetic gastroparesis.

Conditions

  • Diabetic Gastroparesis

Interventions

DEVICE

acupuncture

Patients will be acupuncture with Zhongwan(RN12),needle 1 times a day,30 min/time,5 days for a period of treatment,the treatment interval for two days,three intervention treatment,follow-up after 4 weeks.

DEVICE

acupuncture

Patients in Combination of He-Mu points group,will be acupuncture with Zusanli(ST36) and Zhongwan(RN12),needle 1 times a day,30 min/time,5 days for a period of treatment,the treatment interval for two days,three intervention treatment, follow-up after 4 weeks.

DEVICE

acupuncture

Patients in Control group,will be acupuncture with at the junction of deltoid and biceps,needle 1 times a day,30 min/time,5 days for a period of treatment,the treatment interval for two days,three intervention treatment,follow-up after 4 weeks.

Sponsors & Collaborators

  • The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

    collaborator OTHER

  • Hengyang Traditional Chinese Medicine Hospital

    collaborator OTHER

  • Second People's Hospital of Hunan

    collaborator OTHER

  • Jilin University

    collaborator OTHER

  • Qilu Hospital of Shandong University

    collaborator OTHER

  • Changchun University of Chinese Medicine

    lead OTHER

Principal Investigators

  • Fuchun Wang, master · Director

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-12-31
Completion
2018-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02452489 on ClinicalTrials.gov